Management of infections in patients with leukemia and lymphoma: current concepts and experimental approaches.
D000666:Amphotericin B / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000382:microbiology; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005334:Fever / Q000175:diagnosis / Q000209:etiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000209:etiology / Q000628:therapy*; D007938:Leukemia / Q000150:complications*; D007962:Leukocytes; D008223:Lymphoma / Q000150:complications*; D008712:Methicillin / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy; D010357:Patient Isolators; D010403:Penicillin Resistance; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011113:Polymyxins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D014123:Toxoplasmosis / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy
D000935:Antifungal Agents; D005839:Gentamicins; D011113:Polymyxins; D000667:Ampicillin; D000666:Amphotericin B; D002228:Carbenicillin; D008712:Methicillin; D002512:Cephalothin